CTCELLS is a cutting-edge cancer diagnostics and drug development company, founded on the premise that effective cancer treatment requires tailored solutions for each individual. Leveraging Circulating Tumor Cell (CTC) liquid biopsy technology, CTCELLS leads the industry with its unique automation capabilities, enabling the isolation of all types of circulating tumor cells. With a strong focus on developing innovative cancer treatments, CTCELLS is dedicated to improving patient outcomes by matching cancer characteristics with the most suitable therapies, setting its sights on bringing hope to patients facing challenging cancer types. Join us in our mission to transform the landscape of cancer treatment.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Dalseong, Daegu
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://ctcells.com
- HQ
- Dalseong, Daegu
Ctcells Questions
Ctcells's website is http://ctcells.com
Ctcells's LinkedIn profile is https://kr.linkedin.com/company/ctcells
Ctcells has
7 employees.
View email and phone details for 7
employees at Ctcells.
Ctcells's industry is
Biotechnology Research
Ctcells's top competitors are
Heliowave Technologies Corp,
Cha Bio Group｜차바이오그룹,
Gulf Coast Consortia - Research,
Rokit Genomics,
World Zionist Village,
Protium Science - Cdmo,
Innovative Business Interiors,
Immatics,
Far Biotech,
Y-Biologics.
Ctcells's categories are Biotechnology Research
Ctcells's founding year is 2018
